Skip to main content

Want a detailed portfolio tracker?

Roivant Sciences (ROIV) P/E (2021 - 2026)

Roivant Sciences (ROIV) P/E from Oct 1, 2021 to Jul 21, 2026. The TTM Roivant Sciences (ROIV) P/E is -78.38. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Roivant Sciences (ROIV)

YearP/EChange
2026-78.38+320.20%
2025-18.65-78.42%
2024-86.42+891.94%
2023-8.71+83.94%
2022-4.74+58.49%
2021-2.99N/A

Comparison Roivant Sciences (ROIV) P/E with competitors

Roivant Sciences (ROIV) P/E is -78.38.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.10%
FGENFibroGen Inc0.24-100.31%
CHRSCoherus Biosciences Inc0.85-101.08%
FBIOFortress Biotech Inc0.95-101.21%
ORMPOramed Pharmaceuticals Inc1.50-101.92%
AGENAgenus Inc3.01-103.84%
INVAInnoviva Inc3.15-104.02%
VXRTVaxart Inc3.55-104.53%
CRMDCorMedix Inc3.63-104.63%
CVACCureVac N.V.4.45-105.67%
GLPGGalapagos NV4.86-106.20%
SRPTSarepta Therapeutics Inc4.88-106.23%
ABEOAbeona Therapeutics Inc5.39-106.87%
ABUSArbutus Biopharma Corp5.60-107.14%
ZVRAZevra Therapeutics Inc5.89-107.51%
SPROSpero Therapeutics Inc6.23-107.95%
CGENCompugen Ltd6.31-108.06%
RIGLRigel Pharmaceuticals6.87-108.77%
SLXNSilexion Therapeutics Corp7.30-109.31%
OMEROmeros Corporation9.26-111.81%
AUPHAurinia Pharmaceuticals Inc9.58-112.23%
PLXProtalix BioTherapeutics Inc10.89-113.89%
ACADAcadia Pharmaceuticals Inc11.73-114.96%
TBPHTheravance Biopharma Inc12.26-115.64%
ADMAAdma Biologics Inc12.42-115.84%
HRMYHarmony Biosciences Holdings Inc13.82-117.63%
SABSSAB Biotherapeutics Inc14.14-118.03%
NAGENiagen Bioscience Inc14.82-118.90%
INCYIncyte Corp15.82-120.19%
REGNRegeneron Pharmaceuticals Inc15.86-120.23%
PBYIPuma Biotechnology Inc17.32-122.09%
CPRXCatalyst Pharmaceuticals Inc17.44-122.25%
EXELExelixis Inc17.54-122.37%
TGTXTG Therapeutics Inc18.97-124.20%
MDXGMimedx Group Inc20.55-126.22%
XOMAXOMA Royalty Corp22.87-129.18%
ARGXArgen X SE24.30-131.00%
CTMXCytomX Therapeutics Inc24.82-131.67%
XOMAOXOMA Royalty Corp25.34-132.33%
HALOHalozyme Therapeutics Inc25.62-132.69%
XOMAPXOMA Royalty Corp25.67-132.75%
VRTXVertex Pharmaceuticals Inc27.99-135.72%
RPRXRoyalty Pharma plc - Class A28.69-136.60%
SLNOSoleno Therapeutics Inc29.02-137.02%
ASNDAscendis Pharma A/S30.09-138.38%
LGNDLigand Pharmaceuticals Inc - Class B37.91-148.37%
APLSApellis Pharmaceuticals Inc39.02-149.78%
BMRNBiomarin Pharmaceutical Inc42.21-153.85%
KRYSKrystal Biotech Inc45.34-157.85%
ONCBeiGene Ltd69.54-188.72%
PHARPharming Group N.V.75.03-195.72%
TECHBio-Techne Corp101.96-230.08%
VCELVericel Corp109.92-240.24%
ALNYAlnylam Pharmaceuticals Inc117.96-250.50%
GMABGenmab140.29-278.98%
TLXTelix Pharmaceuticals Ltd162.15-306.87%
CORTCorcept Therapeutics Inc212.86-371.56%